Future studies will examine the mechanistic actions of inhibiting the NF-κB pathway on FUS function and the dynamic interplay between pro-inflammatory signals and mitochondrial function in disease models of ALS/FTD. This evidence concerns the gene NFKB1 and frontotemporal dementia.